Screener
Organogenesis Holdings Inc. ORGO Total Revenue
Total Revenue at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by Organogenesis Holdings Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Organogenesis Holdings Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338049
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenue: | ||||
| Net product revenue | $42,805 | $100,779 | $79,055 | $187,472 |
| Grant income | 950 | 226 | 1,928 | 226 |
| Total revenue | 43,755 | 101,005 | 80,983 | 187,698 |
| Operating expenses: | ||||
| Cost of goods sold | 23,673 | 27,630 | 49,445 | 51,353 |
| Selling, general and administrative | 53,965 | 73,810 | 119,151 | 146,319 |
| Research and development | 18,297 | 10,395 | 33,458 | 21,035 |
Item 1. Unaudited Condensed Consolidated Financial Statements.
FAQ
- What is Organogenesis Holdings Inc.'s total revenue?
- Organogenesis Holdings Inc. (ORGO) reported total revenue of $43.76M in Q2 2026.
- How has Organogenesis Holdings Inc.'s total revenue changed year-over-year?
- Organogenesis Holdings Inc.'s total revenue decreased by 56.7% year-over-year, from $101.01M to $43.76M.
- What is the long-term trend for Organogenesis Holdings Inc.'s total revenue?
- Over 4 years (2021 to 2025), Organogenesis Holdings Inc.'s total revenue has grown at a 4.8% compound annual growth rate (CAGR), from $467.36M to $564.17M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Organogenesis Holdings Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude